Which statement about bipolar disorder management is accurate?

Which statement about bipolar disorder management is accurate?

• A. Onset usually in the 60s; no genetic risk
• B. Group psychoeducation has no benefit
• C. It rarely responds to pharmacotherapy
• D. Onset usually 20s-30s; family history strongest risk factor; group psychoeducation benefits pharmacotherapy

Answer: (D)

The key idea is that bipolar disorder most often starts in early adulthood and has a strong genetic component, and that group psychoeducation can meaningfully augment pharmacologic treatment. Onset in the 20s to 30s fits the typical pattern seen in most patients, whereas onset in the 60s is atypical. In bipolar disorder, family history is one of the strongest risk factors, reflecting a substantial genetic contribution to risk. Pharmacotherapy is a central part of management and many patients respond to mood stabilizers or antipsychotics; saying it rarely responds overlooks the proven effectiveness of these treatments in preventing mood episodes and helping maintain function. Group psychoeducation complements medication by improving adherence, helping patients recognize early warning signs of mood shifts, and reducing relapse, which has been shown to enhance overall treatment outcomes. So, the statement that accurately reflects management is that onset is usually in the 20s–30s; family history is the strongest risk factor; and group psychoeducation benefits pharmacotherapy.

The key idea is that bipolar disorder most often starts in early adulthood and has a strong genetic component, and that group psychoeducation can meaningfully augment pharmacologic treatment.

Onset in the 20s to 30s fits the typical pattern seen in most patients, whereas onset in the 60s is atypical. In bipolar disorder, family history is one of the strongest risk factors, reflecting a substantial genetic contribution to risk. Pharmacotherapy is a central part of management and many patients respond to mood stabilizers or antipsychotics; saying it rarely responds overlooks the proven effectiveness of these treatments in preventing mood episodes and helping maintain function. Group psychoeducation complements medication by improving adherence, helping patients recognize early warning signs of mood shifts, and reducing relapse, which has been shown to enhance overall treatment outcomes.

So, the statement that accurately reflects management is that onset is usually in the 20s–30s; family history is the strongest risk factor; and group psychoeducation benefits pharmacotherapy.